Menu

• Ask a Health Expert about BRONCHIAL SECRETION RETENTION
• Post Your Side Effect related to BRONCHIAL SECRETION RETENTION
• BRONCHIAL SECRETION RETENTION and FDA Warnings
• BRONCHIAL SECRETION RETENTION in Patients Wiki
• Report BRONCHIAL SECRETION RETENTION in Drug Side Effect Survey

BRONCHIAL SECRETION RETENTION side effect

What is BRONCHIAL SECRETION RETENTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Cytarabine Side Effects Report #5564359-4
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Dec 14, 2007. Female patient, weighting 167.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, cerebral haemorrhage, convulsion, hypoxia, pericardial effusion, pneumonia, pulmonary oedema, respiratory failure, tachycardia, . CYTARABINE dosage: 185 MG. During the same period patient was treated with ETOPOSIDE, ACETOPMETAPHIN, ACYCLOVIR, BUPROPRION, DEXAMETHASONE, DIPHENHYDRAMINE, FILGRASTIM, LEVETIRACETAM. Patient was hospitalized. Patient recovered.

Proair Side Effects Report #5574709-0
PROAIR HFA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 21, 2007. Male patient, 44 years of age, weighting 245.0 lb, was diagnosed with asthma and was treated with PROAIR HFA. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, condition aggravated, dyspnoea, . PROAIR HFA dosage: unknown. Patient recovered.

Cisplatin Side Effects Report #5578806-5
Health Professional from UNITED STATES reported CISPLATIN problem on Dec 28, 2007. Male patient, 39 years of age, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, dyspnoea, febrile neutropenia, increased bronchial secretion, tracheostomy malfunction, . CISPLATIN dosage: 72 MG X 3 DAYS. During the same period patient was treated with BEVACIZUMAB, TARCEVA. Patient was hospitalized. Patient recovered.

Haloperidol Side Effects Report #5505261-3
HALOPERIDOL DECANOATE problem was reported by a Physician from JAPAN on Oct 29, 2007. Male patient, 59 years of age, was treated with HALOPERIDOL DECANOATE. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, dysphagia, hypoxic encephalopathy, neuroleptic malignant syndrome, respiratory arrest, . HALOPERIDOL DECANOATE dosage: unknown. Patient was hospitalized. Patient recovered.


Haloperidol Side Effects Report #5515779-5
Physician from JAPAN reported HALOPERIDOL DECANOATE problem on Nov 02, 2007. Male patient, 59 years of age, weighting 154.3 lb, was treated with HALOPERIDOL DECANOATE. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, cardio-respiratory arrest, dysphagia, hypoxic encephalopathy, neuroleptic malignant syndrome, pneumonia, subcutaneous haematoma, . HALOPERIDOL DECANOATE dosage: unknown. During the same period patient was treated with RISPERIDONE, LORAZEPAM, MECOBALAMIN, CLOSTRIDIUM BUTYRICUM, BIPERIDIN, PROMETHAZINE, TANDOSPIRONE. Patient was hospitalized. Patient recovered.

Haloperidol Side Effects Report #5485107-2
HALOPERIDOL DECANOATE problem was reported by a Physician from JAPAN on Oct 05, 2007. Male patient, 59 years of age, was treated with HALOPERIDOL DECANOATE. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, hypoxic encephalopathy, neuroleptic malignant syndrome, respiratory arrest, . HALOPERIDOL DECANOATE dosage: unknown. Patient was hospitalized. Patient recovered.

Oxynorm Side Effects Report #5443238-7
Consumer or non-health professional from reported OXYNORM CAPSULES problem on Aug 23, 2007. Female patient, 84 years of age, was diagnosed with pain and was treated with OXYNORM CAPSULES. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, respiratory failure, sopor, . OXYNORM CAPSULES dosage: 5 MG, DAILY. During the same period patient was treated with LEVOTHYROX, XANAX, IMOVANE, PAROXETINE, AUGMENTIN. Patient died on 10/24/2006.

Spiriva Side Effects Report #5428114-8
SPIRIVA problem was reported by a Consumer or non-health professional from GERMANY on Aug 27, 2007. Female patient, weighting 130.1 lb, was diagnosed with asthma, bronchitis chronic and was treated with SPIRIVA. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, constipation, dyspnoea, . SPIRIVA dosage: unknown. During the same period patient was treated with THEOPHYLLINE, KORTISONSPRAY, SEREVENT, BUDESONIDE. Patient recovered.

Rebif Side Effects Report #5403310-4
Consumer or non-health professional from UNITED STATES reported REBIF problem on July 20, 2007. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, choking, . REBIF dosage: unknown. Patient died on 07/19/2007.


Rebif Side Effects Report #5403310-4
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, choking, . REBIF dosage: unknown. Patient died on 07/19/2007.

Cerezyme Side Effects Report #5741394-4
Physician from AUSTRALIA reported CEREZYME problem on May 04, 2008. Male patient, child 3 years of age, weighting 26.46 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, convulsion, cyanosis, developmental delay, respiratory failure, . CEREZYME dosage: unknown. Patient died on 03/16/2008.

Cerezyme Side Effects Report #5692868-6
CEREZYME problem was reported by a Pharmacist from AUSTRALIA on Mar 26, 2008. Female patient, child 3 years of age, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, . CEREZYME dosage: unknown. Patient died on 03/16/2008.

Oxycontin Side Effects Report #5350956-8
Consumer or non-health professional from reported OXYCONTIN problem on May 31, 2007. Female patient was treated with OXYCONTIN. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, respiratory failure, sopor, . OXYCONTIN dosage: 10 MG, DAILY. Patient died.

Asasol Side Effects Report #5330416-0
ASASOL problem was reported by a Physician from UNITED KINGDOM on Apr 30, 2007. Female patient, 28 years of age, was diagnosed with colitis ulcerative and was treated with ASASOL. After drug was administered, patient experienced the following problems/side effects: bronchial secretion retention, bronchial wall thickening, bronchiectasis, bronchitis bacterial, colitis ulcerative, condition aggravated, eosinophilia, nasal congestion, weight decreased, . ASASOL dosage: 400 MG THREE TIMES A DAY, ORAL. Patient recovered.


Prednisone Side Effects Report #5600529-4
Consumer or non-health professional from reported PREDNISONE problem on Jan 21, 2008. Female patient, child 8 years of age, was diagnosed with cystic fibrosis and was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: atelectasis, bronchial secretion retention, bronchopulmonary aspergillosis, methicillin-resistant staphylococcal aureus test positive, . PREDNISONE dosage: unknown. During the same period patient was treated with STEROID, ALBUTEROL, PULMOZYME. Patient was hospitalized. Patient recovered.

Lioresal Side Effects Report #5606774-6
LIORESAL problem was reported by a Physician from UNITED STATES on Jan 15, 2008. Male patient was diagnosed with muscle spasticity and was treated with LIORESAL. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial secretion retention, hypotension, hypoxia, pneumonia, sepsis, urinary tract infection pseudomonal, . LIORESAL dosage: unknown. Patient was hospitalized. Patient died on 01/11/2008.

Advair Side Effects Report #5563042-9
Pharmacist from UNITED STATES reported ADVAIR DISKUS problem on Dec 05, 2007. Male patient, child 10 years of age, weighting 125.2 lb, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial secretion retention, cardiac arrest, cardio-respiratory arrest, cyanosis, dyspnoea, increased appetite, injury, lung hyperinflation, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with FLOVENT, ALBUTEROL. Patient was hospitalized. Patient died on 11/14/2004.

Advair Side Effects Report #5569631-X
ADVAIR DISKUS problem was reported by a Pharmacist from UNITED STATES on Dec 10, 2007. Male patient, child 10 years of age, weighting 125.2 lb, was diagnosed with asthma, wheezing, attention deficit/hyperactivity disorder and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial secretion retention, cardiac arrest, cardio-respiratory arrest, cyanosis, dyspnoea, increased appetite, injury, lung hyperinflation, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with FLOVENT, ALBUTEROL, CONCERTA. Patient was hospitalized. Patient died on 11/14/2004.

Novantrone Side Effects Report #5494057-7
Health Professional from UNITED STATES reported NOVANTRONE problem on Oct 16, 2007. Male patient, 63 years of age, was treated with NOVANTRONE. After drug was administered, patient experienced the following problems/side effects: blood pressure immeasurable, bronchial secretion retention, cardiac disorder, discomfort, dyspnoea, ejection fraction decreased, malaise, muscle spasms, nasal mucosal disorder, . NOVANTRONE dosage: unknown. Patient died on 09/29/2007.


Advair Side Effects Report #5463165-9
ADVAIR DISKUS problem was reported by a Pharmacist from UNITED STATES on Sept 17, 2007. Male patient, child 10 years of age, weighting 125.2 lb, was diagnosed with asthma and was treated with ADVAIR DISKUS. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial secretion retention, cardiac arrest, cardio-respiratory arrest, cyanosis, dyspnoea, injury, lung hyperinflation, pain, . ADVAIR DISKUS dosage: unknown. During the same period patient was treated with FLOVENT, ALBUTEROL. Patient was hospitalized. Patient died on 11/14/2004.

Salmeterol Side Effects Report #5398266-7
Physician from UNITED STATES reported SALMETEROL XINAFOATE problem on July 12, 2007. Female patient, 20 years of age, was diagnosed with asthma and was treated with SALMETEROL XINAFOATE. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial secretion retention, cardiac arrest, chills, condition aggravated, cyanosis, emphysema, eosinophilic pneumonia, peripheral coldness, . SALMETEROL XINAFOATE dosage: unknown. During the same period patient was treated with ALBUTEROL SPIROS, IPRATROP, FLUTICASONE PROPIONATE, PREDNISONE, AZITHROMYCIN, CLARITHYROMYCIN, THEOPHYLLINE, MONTELUKAST. Patient was hospitalized. Patient died.

Salmeterol Side Effects Report #5398266-7
SALMETEROL XINAFOATE problem was reported by a Physician from UNITED STATES on July 12, 2007. Female patient, 20 years of age, was diagnosed with asthma and was treated with SALMETEROL XINAFOATE. After drug was administered, patient experienced the following problems/side effects: asthma, bronchial secretion retention, cardiac arrest, chills, condition aggravated, cyanosis, emphysema, eosinophilic pneumonia, peripheral coldness, . SALMETEROL XINAFOATE dosage: unknown. During the same period patient was treated with ALBUTEROL SPIROS, IPRATROP, FLUTICASONE PROPIONATE, PREDNISONE, AZITHROMYCIN, CLARITHYROMYCIN, THEOPHYLLINE, MONTELUKAST. Patient was hospitalized. Patient died.

Cytarabine Side Effects Report #5789167-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on June 25, 2008. Female patient, weighting 167.6 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: aspiration tracheal abnormal, bronchial secretion retention, cerebral haemorrhage, convulsion, leukostasis, mental status changes, myopathy, pericardial effusion, pneumonia, . CYTARABINE dosage: 185 MG. During the same period patient was treated with ETOPOSIDE, ACETOPMETAPHIN, ACYCLOVIR, BUPROPION, DEXAMETHASONE, DIPHENHYDRAMINE, FILGRASTIM, LEVETIRACETAM. Patient was hospitalized. Patient recovered.

Pemetrexed Side Effects Report #5326525-2
PEMETREXED problem was reported by a Physician from INDIA on May 04, 2007. Male patient, 42 years of age, weighting 70.55 lb, was diagnosed with prophylaxis of nausea and vomiting, prophylaxis against gastrointestinal ulcer, antiemetic supportive care, dental disorder prophylaxis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial secretion retention, lung infection, . PEMETREXED dosage: 595 MG, ONCE EVERY 21 DAYS. During the same period patient was treated with ATIVAN, GRANISETRON, PERINORM, RANTAC, TANTUM, PANTOPRAZOLE, ONDANSETRON, CANDID B. Patient was hospitalized. Patient recovered.

Combivent Side Effects Report #5329106-X
Consumer or non-health professional from UNITED STATES reported COMBIVENT problem on May 17, 2007. Female patient, 57 years of age, was diagnosed with chronic obstructive pulmonary disease, dyspnoea, asthma and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: breast cancer, bronchial secretion retention, sputum retention, vomiting, . COMBIVENT dosage: unknown. During the same period patient was treated with ADVAIR DISKUS, SINGULAIR. Patient was hospitalized. Patient recovered.

Pemetrexed Side Effects Report #5337117-3
PEMETREXED problem was reported by a Physician from INDIA on May 17, 2007. Male patient, 42 years of age, weighting 70.55 lb, was diagnosed with prophylaxis of nausea and vomiting, prophylaxis against gastrointestinal ulcer, antiemetic supportive care, dental disorder prophylaxis and was treated with PEMETREXED. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, bronchial secretion retention, cardio-respiratory arrest, lung injury, . PEMETREXED dosage: 595 MG, ONCE EVERY 21 DAYS. During the same period patient was treated with ATIVAN, GRANISETRON, PERINORM, RANTAC, TANTUM, PANTOPRAZOLE, ONDANSETRON, CANDID B. Patient was hospitalized. Patient died on 05/12/2007.

Erlotinib Side Effects Report #5677828-3
Physician from UNITED STATES reported ERLOTINIB problem on Mar 04, 2008. Male patient, 63 years of age, weighting 147.0 lb, was diagnosed with tonsil cancer and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: areflexia, aspiration, bronchial secretion retention, dysphagia, ejection fraction decreased, laryngitis, mucosal inflammation, pneumonia, saliva altered, . ERLOTINIB dosage: 150 MG. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL, LORTAB, PLAVIX, INHALER, KLONOPIN. Patient was hospitalized. Patient recovered.

Diamox Side Effects Report #5573920-2
DIAMOX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 05, 2007. Male patient, child 12 years of age, was diagnosed with asthma and was treated with DIAMOX. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood magnesium increased, bronchial secretion retention, cardiogenic shock, disseminated intravascular coagulation, duodenal ulcer haemorrhage, erosive duodenitis, gastritis, gastrointestinal necrosis, . DIAMOX dosage: unknown. During the same period patient was treated with ALBUTEROL SULPHATE, FENTANYL, IBUPROFEN, LASIX, PROVENTIL, TERBUTALINE SULPHATE, ATROVENT. Patient was hospitalized. Patient died on 04/12/1997.

Synagis Side Effects Report #5483575-3
Physician from UNITED STATES reported SYNAGIS problem on Oct 01, 2007. Female patient, weighting 12.00 lb, was treated with SYNAGIS. After drug was administered, patient experienced the following problems/side effects: apnoea, aspiration, bronchial secretion retention, pulse absent, respiratory arrest, . SYNAGIS dosage: unknown. Patient died on 03/31/2007.

Myozyme Side Effects Report #5484870-4
MYOZYME problem was reported by a Physician from FRANCE on Sept 26, 2007. Male patient, weighting 26.46 lb, was diagnosed with glycogen storage disease type ii and was treated with MYOZYME. After drug was administered, patient experienced the following problems/side effects: anoxia, aspiration, bronchial secretion retention, cardiac failure, cardio-respiratory arrest, catheter related infection, convulsion, hypotonia, lung infection, . MYOZYME dosage: 30 MG/KG Q2WKS IV. During the same period patient was treated with RENITEC, FORTUM, PHOSPHONEUROS. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5453640-5
Consumer or non-health professional from UNITED STATES reported CYCLOSPORINE problem on Sept 05, 2007. Male patient, 45 years of age, was diagnosed with renal transplant and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: acidosis, blood creatinine increased, bronchial secretion retention, cardiac arrest, cryptogenic organising pneumonia, decubitus ulcer, dyspnoea, haemodialysis, hyperkalaemia, . CYCLOSPORINE dosage: 550 MG, UNK. During the same period patient was treated with CELLCEPT, VITAMIN CAP, ELAVIL, ZOLOFT, PREDNISONE. Patient was hospitalized. Patient recovered.